OC
COYA icon

Oppenheimer & Co’s Coya Therapeutics COYA Stock Holding History

Oppenheimer & Co’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.9K Buy
18,000
+4,000
+29% +$18.7K ﹤0.01% 1655
2025
Q4 		$81.2K Buy
+14,000
New +$85.1K ﹤0.01% 1501

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Oppenheimer & Co's COYA Position: Q1 2026 in Review

Oppenheimer & Co increased its Coya Therapeutics (COYA) stake by 29% in Q1 2026, buying an estimated $18.7K and bringing the position to 18,000 shares worth $70.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1655.

Oppenheimer & Co first reported a position in COYA in Q4 2025 and has held it in 2 quarters since. The position peaked at $81.2K in Q4 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Oppenheimer & Co held 18,000 shares of Coya Therapeutics worth $70.9K as of Q1 2026.
  • Oppenheimer & Co bought 4,000 Coya Therapeutics shares in Q1 2026, an estimated $18.7K.
  • Coya Therapeutics made up ﹤0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1655 holding.
  • Oppenheimer & Co first reported a position in Coya Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Oppenheimer & Co's Coya Therapeutics position peaked at $81.2K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.